Prurigo Nodularis and Chronic Itch: What’s the Connection?
Intense itch is a common feature of prurigo nodularis. Why is this the case? Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Raj J. Chovatiya, associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School. Dr. Chovatiya, who has a PhD in immunology, outlines the science behind the “unbreakable loop” of chronic itch in prurigo …
Intense itch is a common feature of prurigo nodularis. Why is this the case? Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Raj J. Chovatiya, associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School. Dr. Chovatiya, who has a PhD in immunology, outlines the science behind the “unbreakable loop” of chronic itch in prurigo … Continue reading "Prurigo Nodularis and Chronic Itch: What’s the Connection?"
Summer means news articles on sun protection and the dangers of tanning, and for the first time in more than 20 years, the news includes FDA approval of a sunscreen ingredient. As detailed by NPR, newly approved bemotrizinol protects against both UVA and UVB rays, and is photo stable, offering longer protection than other U.S. sunscreens. Even the Environmental Working Group (EWG) is excited about … 
Physician burnout is pervasive in medicine. A Stanford Medicine-led study of U.S. physicians conducted in 2023 and 2024 found nearly half experienced at least one symptom of burnout. While the broader conversation may raise burnout as a concerning issue, the lived experience of physicians tells a different story. Despite the fact burnout is so prevalent, the demands on physicians remain unchanged: … 
Post-acne scars can be disfiguring and require a creative treatment approach in patients with skin of color, according to Dr. Michelle Henry, clinical instructor of dermatology at Weill Cornell Medical College. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Henry, who shared what energy-based devices she uses in her practice and how she chooses a device based on a p … 
Lebrikizumab is a humanized immunoglobulin G4 (IgG4) monoclonal antibody that selectively targets IL-13, a key cytokine implicated in the pathogenesis of type 2 inflammatory diseases.1 Lebrikizumab binds IL-13 with high affinity and a slow dissociation rate, which prevents heterodimerization of the IL-13 receptor alpha-1 subunit (IL-13Rα1) with the IL-4 receptor alpha (IL-4Rα) signaling complex. …